Isotype controls are antibodies that match the primary antibody’s host species, isotype, and conjugate but have no known target in your sample. They are intended to reveal non-specific binding caused by Fc receptor interactions or sticky antibody behavior. But do you always need them? The answer depends on your application and has changed with evolving best practices.
An isotype control is an antibody of the same class (IgG1, IgG2a, IgG2b, etc.), same species (mouse, rabbit, rat), and same conjugate (FITC, PE, APC, etc.) as your primary antibody, but it targets an irrelevant antigen not present in your experimental system. It is used at the same concentration as the primary antibody.
Example: If your primary antibody is mouse IgG1-PE anti-CD4, the corresponding isotype control is mouse IgG1-PE directed against an irrelevant target (e.g., keyhole limpet hemocyanin, KLH).
| Application | Isotype Control Needed? | Why |
|---|---|---|
| Flow cytometry (surface markers) | Debated—FMO often preferred | Isotype controls can underestimate or overestimate background; FMO captures spillover from other channels |
| Flow cytometry (intracellular staining) | Yes—more useful here | Permeabilization increases non-specific antibody trapping; isotype controls detect this artifact |
| IHC / IF | Yes | Fc receptor expression on tissue macrophages and endogenous Ig can cause non-specific staining |
| In vivo experiments | Yes—critical | Must control for Fc-mediated immune effects independent of target binding |
| Western blot | Rarely needed | Non-specific binding is better assessed by omitting primary antibody entirely |
| ELISA | Sometimes | Useful when developing new assays to establish background signal level |
The flow cytometry field has largely moved toward Fluorescence Minus One (FMO) controls as the preferred gating control:
| Control Type | What It Shows | Limitation |
|---|---|---|
| Isotype control | Non-specific binding of the antibody format | Does not account for spectral spillover from other channels; may not match the exact binding behavior of the specific antibody |
| FMO (Fluorescence Minus One) | Where to place the gate by showing the signal spread from all other fluorophores minus the one of interest | Does not detect Fc receptor-mediated non-specific binding |
| Unstained | Autofluorescence level only | Misses both non-specific binding and spillover |
Best Practice for Flow Cytometry
Use FMO controls for gating decisions (where to draw the positive/negative boundary). Add isotype controls only when you suspect Fc receptor-mediated binding (e.g., staining monocytes, macrophages, or activated T cells that upregulate FcγR).
In vivo experiments represent the strongest case for isotype controls. When you inject a therapeutic antibody into a mouse, the observed effect could be:
An isotype control antibody—same isotype, same dose, same route, same endotoxin level—controls for the second and third effects. Without it, you cannot attribute your result to target engagement.
Common Mistake
Using a polyclonal IgG preparation (e.g., purified normal mouse IgG) as an isotype control for a monoclonal antibody. Polyclonal IgG has different Fc glycosylation, aggregation, and binding properties than a monoclonal. Always use a monoclonal isotype control matched to your primary.
+86-27-87433958
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский